Form 4: Amneal Pharmaceuticals Executive Receives Stock Grant
Insider Transaction (Form 4)
Chintu Patel, Co-CEO and a Director of Amneal Pharmaceuticals, Inc., received 6,381,734 shares of common stock on August 10, 2026.
Summary
- Grant/award: acquired 6,381,734 Class A Common Stock on August 10, 2026; holds 6,381,734 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Chintu Patel — Director, Officer (Co-CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Grant/award | Class A Common Stock | 6,381,734 | — | — | 6,381,734 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Grant/award (6,381,734 shares) |
Keywords
insider transaction, Form 4, AMRX, Amneal Pharmaceuticals, Inc., neutral, Chintu Patel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.